TRDA
Entrada Therapeutics Inc.
Company Overview
| Mkt Cap | $279.57M | Price | $6.95 |
| Volume | 145.25K | Change | +0.72% |
| P/E Ratio | 4.3 | Open | $6.89 |
| Revenue | $210.8M | Prev Close | $6.90 |
| Net Income | $65.6M | 52W Range | $4.93 - $21.79 |
| Div Yield | N/A | Target | $18.50 |
| Overall | 54 | Value | 60 |
| Quality | 44 | Technical | 58 |
No chart data available
Stock Overview
Updated DailyEntrada Therapeutics Inc. (TRDA) is a leading diversified company in the business industry, currently trading at $6.95 with a market capitalization of $279.57 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating below-average quality metrics with a MarketXLS quality score of 44.
Today's trading session shows TRDA with a volume of 145K shares. The stock opened down 0.14% from yesterday's close of $6.90. Current analyst estimates project earnings of $-3.59 per share for this year, with next year targeting $-4.58.
TRDA demonstrates neutral technical outlook based on technical analysis. The company trades on the NSD exchange.
Key investment considerations for TRDA include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 166.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:16 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRDA | $6.95 | +0.7% | 145.25K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Entrada Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW